Medicinova Statistics
Medicinova (MNOV) Stock Statistics & Valuation Metrics
Total Valuation
Medicinova has a market cap or net worth of $71.47M. The enterprise value is $38.79T.
- Market Cap
- $71.47M
- Enterprise Value
- $38.79T
Share Statistics
Medicinova has 51,232,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 51,232,670
- Owned by Insiders
- 12.25%
- Owned by Institutions
- 12.63%
Financial Efficiency
Medicinova’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -31.63%.
- Return on Equity (ROE)
- -0.29
- Return on Assets (ROA)
- -0.26
- Return on Invested Capital (ROIC)
- -31.63%
- Return on Capital Employed (ROCE)
- -0.32
- Revenue Per Employee
- 68.28K
- Profits Per Employee
- -2.00M
- Employee Count
- 6
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Medicinova is -6.42. Medicinova’s PEG ratio is -0.74.
- PE Ratio
- -6.42
- PS Ratio
- 76.38
- PB Ratio
- 1.68
- Price to FCF
- -7.29
- Price to Operating Cash Flow
- -7.03
- PEG Ratio
- -0.74
Income Statement
In the last 12 months, Medicinova had revenue of 409.66K and earned -12.00M in profits. Earnings per share was -0.24.
- Revenue
- 409.66K
- Gross Profit
- 31.05K
- Operating Income
- -13.28M
- Pretax Income
- -11.99M
- Net Income
- -12.00M
- EBITDA
- -11.97M
- Earnings Per Share (EPS)
- -0.24
Cash Flow
In the last 12 months, operating cash flow was -9.79M and capital expenditures -7,924, giving a free cash flow of -9.80M billion.
- Operating Cash Flow
- -9.79M
- Free Cash Flow
- -9.80M
- Free Cash Flow per Share
- -0.20
Dividends & Yields
Medicinova pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.71%
- Earnings Yield
- -15.31%
Stock Price Statistics
- Beta
- 0.57
- 52-Week Price Change
- -9.42%
- 50-Day Moving Average
- 1.78
- 200-Day Moving Average
- 1.50
- Relative Strength Index (RSI)
- 39.96
- Average Volume (3m)
- 331.78K
Important Dates
Medicinova upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Apr 26, 2023
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Medicinova as a current ratio of 8.16, with Debt / Equity ratio of 0.47%
- Current Ratio
- 8.16
- Quick Ratio
- 8.16
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.56
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Medicinova has paid 5,994 in taxes.
- Income Tax
- 5,994
- Effective Tax Rate
- -0.00
Enterprise Valuation
Medicinova EV to EBITDA ratio is -3.98, with an EV/FCF ratio of -4.37.
- EV to Sales
- 45.74
- EV to EBITDA
- -3.98
- EV to Free Cash Flow
- -4.37
- EV to Operating Cash Flow
- -4.37
Balance Sheet
Medicinova has $29.26M in cash and marketable securities with $590.63K in debt, giving a net cash position of $28.67M billion.
- Cash & Marketable Securities
- $29.26M
- Total Debt
- $590.63K
- Net Cash
- $28.67M
- Net Cash Per Share
- $0.56
- Tangible Book Value Per Share
- $0.54
Margins
Gross margin is 46.81%, with operating margin of -1232.17%, and net profit margin of -1127.01%.
- Gross Margin
- 46.81%
- Operating Margin
- -1232.17%
- Pretax Margin
- -1126.37%
- Net Profit Margin
- -1127.01%
- EBITDA Margin
- -1148.27%
- EBIT Margin
- -1150.11%
Analyst Forecast
The average price target for Medicinova is $7.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $7.33
- Price Target Upside
- 425.69% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- 262.80%
- EPS Growth Forecast
- 12.54%
Scores
- Smart Score
- 4
- AI Score
- ―

